Corey S Goodman has an estimated net worth of $51 Million. This is based on reported shares across multiple companies, which include PFIZER INC, Checkmate Pharmaceuticals, Inc., RENOVIS INC, RayzeBio, Inc., Ventyx Biosciences, Inc., ALX ONCOLOGY HOLDINGS INC, Akero Therapeutics, Inc., Metacrine, Inc., IMPEL NEUROPHARMA INC, Elevation Oncology, Inc., PRECISION BIOSCIENCES INC, and Artiva Biotherapeutics, Inc..

2008 was Corey S Goodman's most active year for acquiring shares with 22 total transactions. Corey S Goodman's most active month to acquire stocks was the month of May. 2006 was Corey S Goodman's most active year for disposing of shares, totalling 200 transactions. Corey S Goodman's most active month to dispose stocks was the month of March. 2020 saw Corey S Goodman paying a total of $22,140,000.00 for 14,795,091 shares, this is the most they've acquired in one year. In 2020 Corey S Goodman cashed out on 35,822,664 shares for a total of $20,743,395.94, their largest year based on trade value.